The D826V point mutation in IREB2 induces lipogenesis in adipose tissues
Open Access
- 30 January 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1724485
Abstract
Background: IREB2 is an RNA-binding protein that modulates cellular iron uptake and storage by regulating ferritin expression. Mutations in the IREB2 gene have been shown to induce degradation of the IREB2 protein, resulting in the upregulation of FTH1 protein expression, which contributes to iron storage. This study investigates the potential mechanism of the Ireb2 D826V/D826V mutation on lipid biosynthesis for the first time. Results: In this study, it was discovered for the first time that Ireb2 D826V/D826V mice exhibited increased body weight, hypertrophic adipocytes, iron and lipid accumulation. RNA-sequencing analysis suggests that the Ireb2 D826V/D826V mutation potentially activates pathways involved in fatty acid and triglyceride biosynthesis. This activation is evidenced by the upregulation of lipid biosynthetic genes, including Fasn , Acaca , Acly , Fgfr4 , and Egr1 , along with their corresponding protein expressions in Ireb2 D826V/D826V mice. These molecular changes occur alongside the degradation of IREB2, an increase in FTH1 expression and iron accumulation in tissues. Metabolomic analysis confirmed that the Ireb2 D826V/D826V mutation indeed elevated the levels of certain fatty acids and triglyceride components in epWAT. Moreover, in vitro experiments utilizing adipocytes confirmed that the Ireb2 D826V/D826V mutation augmented fatty acid and triglyceride biosynthesis, as well as the expression of associated proteins, contingent upon iron accumulation. Conclusion: The Ireb2 D826V/D826V mutation is linked to the degradation of IREB2, increased expression of FTH1, and iron accumulation. These molecular alterations are associated with elevated protein levels of ACACA, ACLY, FASN, EGR1, and FGFR4, which correlate with enhanced lipid biosynthesis and subsequent weight gain. This study elucidates a link between dysregulated iron storage, mediated via the IREB2-FTH1 axis, and the upregulation of key lipogenic genes, resulting in enhanced lipid biosynthesis. These findings underscore a potential relationship between iron metabolism and obesity, suggesting that iron homeostasis could serve as a valuable target for further mechanistic investigation and therapeutic development in the context of obesity.Keywords
Funding Information
- National Natural Science Foundation of China (32300627)
- National Natural Science Foundation of China (82371864)
- Natural Science Foundation of Henan Province (232300421281)
- Natural Science Foundation of Henan Province (232300421121)
This publication has 35 references indexed in Scilit:
- Comprehensive bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in LPS-induced acute lung injuryInternational Immunopharmacology, 2025
- Iron-Mediated Regulation in Adipose Tissue: A Comprehensive Review of Metabolism and Physiological EffectsCurrent Obesity Reports, 2025
- Adipocyte-derived ferroptotic signaling mitigates obesityCell Metabolism, 2024
- CD14loCD301b+ macrophages gathering as a proangiogenic marker in adipose tissuesJournal of Lipid Research, 2024
- IFIT2 mediates iron retention and cholesterol efflux in atherosclerosisInternational Immunopharmacology, 2024
- The involvement of IRP2-induced ferroptosis through the p53-SLC7A11-ALOX12 pathway in Parkinson's diseaseFree Radical Biology and Medicine, 2024
- FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinomaJournal of Hepatology, 2024
- Adipose knockout of H-ferritin improves energy metabolism in miceMolecular Metabolism, 2024
- Iron increases lipid deposition via oxidative stress-mediated mitochondrial dysfunction and the HIF1α-PPARγ pathwayCellular and Molecular Life Sciences, 2022
- Deletion of H-ferritin in macrophages alleviates obesity and diabetes induced by high-fat diet in miceDiabetologia, 2020